IL1B and cervical cancer: In addition, a shorter OS time for postoperative patients with cervical cancer was observed between IL-1β high and IL-1β low (40.6 months vs. 82.0 months; P = 0.038) and between IL-8high and IL-8low (41.2 months vs. 82.0 months; P = 0.062).